Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: Implications for the pathogenesis of diabetes mellitus

American Journal of Physiology - Cell Physiology

Volumn 310, Issue 7, 2016, Pages C558-C567

  Urbano, Francesca ^a   Filippello, Agnese ^a   Di Pino, Antonino ^a   Barbagallo, Davide ^b   Di Mauro, Stefania ^a   Pappalardo, Alessandro ^a   Rabuazzo, Agata Maria ^a   Purrello, Michele ^b   Purrello, Francesco ^a   Piro, Salvatore ^a  

^a UNIVERSITY OF CATANIA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

Author keywords

ATP; Glucagon like peptide 1; Gut hormones; Incretins; Intestinal L cell; Metabolism; UCP2

Indexed keywords

ADENOSINE TRIPHOSPHATE; GLIBENCLAMIDE; GLUCAGON LIKE PEPTIDE 1; GLUCOSE; INCRETIN; SMALL INTERFERING RNA; UNCOUPLING PROTEIN 2; ION CHANNEL; MITOCHONDRIAL PROTEIN; MITOCHONDRIAL UNCOUPLING PROTEIN 2;

ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; GLUCOSE TRANSPORT; GLUCOTOXICITY; HYPERGLYCEMIA; MITOCHONDRIAL MEMBRANE POTENTIAL; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; ANIMAL; BIOSYNTHESIS; CELL LINE; DRUG EFFECTS; GENE SILENCING; GENETIC TRANSFECTION; GENETICS; INTESTINE MUCOSA; METABOLISM; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; POLYMERASE CHAIN REACTION; SECRETION (PROCESS); WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CELL LINE; DIABETES MELLITUS, TYPE 2; GENE KNOCKDOWN TECHNIQUES; GLUCAGON-LIKE PEPTIDE 1; GLUCOSE; INTESTINAL MUCOSA; ION CHANNELS; MICE; MITOCHONDRIAL PROTEINS; POLYMERASE CHAIN REACTION; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 84982889717     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00148.2015     Document Type: Article

References (59)

1. Allister EM, Robson-Doucette CA, Prentice KJ, Hardy AB, Sultan S, Gaisano HY, Kong D, Gilon P, Herrera PL, Lowell BB, Wheeler MB. UCP2 regulates the glucagon response to fasting and starvation. Diabetes 62: 1623–1633, 2013.
2. Anello M, Rabuazzo AM, Degano C, Caltabiano V, Patane G, Vigneri R, Purrello F. Fast reversibility of glucose-induced desensitization in rat pancreatic islets. Evidence for an involvement of ionic fluxes. Diabetes 45: 502–506, 1996.
3. Anello M, Spampinato D, Piro S, Purrello F, Rabuazzo AM. Glucosamine- induced alterations of mitochondrial function in pancreatic betacells: possible role of protein glycosylation. Am J Physiol Endocrinol Metab 287: E602–E608, 2004.
4. Barbagallo D, Piro S, Condorelli AG, Mascali LG, Urbano F, Parrinello N, Monello A, Statello L, Ragusa M, Rabuazzo AM, Di Pietro C, Purrello F, Purrello M. miR-296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic alpha cells to cytokine-induced apoptosis as compared to beta cells. BMC Genomics 14: 62, 2013.
5. Bodyak N, Rigor DL, Chen YS, Han Y, Bisping E, Pu WT, Kang PM. Uncoupling protein 2 modulates cell viability in adult rat cardiomyocytes. Am J Physiol Heart Circ Physiol 293: H829–H835, 2007.
6. Brubaker PL, Schloos J, Drucker DJ. Regulation of glucagon-like peptide-1 synthesis and secretion in the GLUTag enteroendocrine cell line. Endocrinology 139: 4108–4114, 1998.
7. Campbell JE, Drucker DJ. Pharmacology, physiology, and mechanisms of incretin hormone action. Cell Metab 17: 819–837, 2013.
8. Cancelas J, Sancho V, Villanueva-Penacarrillo ML, Courtois P, Scott FW, Valverde I, Malaisse WJ. Glucagon-like peptide 1 content of intestinal tract in adult rats injected with streptozotocin either during neonatal period or 7 d before sacrifice. Endocrine 19: 279–286, 2002.
9. Chen Y, Li ZY, Yang Y, Zhang HJ. Uncoupling protein 2 regulates glucagon-like peptide-1 secretion in L-cells. World J Gastroenterol 18: 3451–3457, 2012.
10. Chen Y, Zhang J, Zhang XY. 2-NBDG as a marker for detecting glucose uptake in reactive astrocytes exposed to oxygen-glucose deprivation in vitro. J Mol Neurosci 55: 126–130, 2015.
11. Diakogiannaki E, Gribble FM, Reimann F. Nutrient detection by incretin hormone secreting cells. Physiol Behav 106: 387–393, 2012.
12. Diao J, Allister EM, Koshkin V, Lee SC, Bhattacharjee A, Tang C, Giacca A, Chan CB, Wheeler MB. UCP2 is highly expressed in pancreatic alpha-cells and influences secretion and survival. Proc Natl Acad Sci USA 105: 12057–12062, 2008.
13. Drucker DJ, Jin T, Asa SL, Young TA, Brubaker PL. Activation of proglucagon gene transcription by protein kinase-A in a novel mouse enteroendocrine cell line. Mol Endocrinol 8: 1646–1655, 1994.
14. Drucker DJ, Lee YC, Asa SL, Brubaker PL. Inhibition of pancreatic glucagon gene expression in mice bearing a subcutaneous glucagonproducing GLUTag transplantable tumor. Mol Endocrinol 6: 2175–2184, 1992.
15. Elrick H, Stimmler L, Hlad CJ Jr, Arai Y. Plasma insulin response to oral and intravenous glucose administration. J Clin Endocrinol Metab 24: 1076–1082, 1964.
16. Gautier-Stein A, Soty M, Chilloux J, Zitoun C, Rajas F, Mithieux G. Glucotoxicity induces glucose-6-phosphatase catalytic unit expression by acting on the interaction of HIF-1alpha with CREB-binding protein. Diabetes 61: 2451–2460, 2012.
17. Gohring I, Sharoyko VV, Malmgren S, Andersson LE, Spegel P, Nicholls DG, Mulder H. Chronic high glucose and pyruvate levels differentially affect mitochondrial bioenergetics and fuel-stimulated insulin secretion from clonal INS-1 832/13 cells. J Biol Chem 289: 3786–3798, 2014.
18. Gribble FM, Williams L, Simpson AK, Reimann F. A novel glucosesensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line. Diabetes 52: 1147–1154, 2003.
19. Holst JJ, Vilsboll T, Deacon CF. The incretin system and its role in type 2 diabetes mellitus. Mol Cell Endocrinol 297: 127–136, 2009.
20. Jensen DH, Aaboe K, Henriksen JE, Volund A, Holst JJ, Madsbad S, Krarup T. Steroid-induced insulin resistance and impaired glucose tolerance are both associated with a progressive decline of incretin effect in first-degree relatives of patients with type 2 diabetes. Diabetologia 55: 1406–1416, 2012.
21. Joseph JW, Koshkin V, Zhang CY, Wang J, Lowell BB, Chan CB, Wheeler MB. Uncoupling protein 2 knockout mice have enhanced insulin secretory capacity after a high-fat diet. Diabetes 51: 3211–3219, 2002.
22. Kappe C, Zhang Q, Holst JJ, Nystrom T, Sjoholm A. Evidence for paracrine/autocrine regulation of GLP-1-producing cells. Am J Physiol Cell Physiol 305: C1041–C1049, 2013.
23. Knop FK, Vilsboll T, Hojberg PV, Larsen S, Madsbad S, Volund A, Holst JJ, Krarup T. Reduced incretin effect in type 2 diabetes: cause or consequence of the diabetic state? Diabetes 56: 1951–1959, 2007.
24. Kong D, Vong L, Parton LE, Ye C, Tong Q, Hu X, Choi B, Bruning JC, Lowell BB. Glucose stimulation of hypothalamic MCH neurons involves KATP channels, is modulated by UCP2, and regulates peripheral glucose homeostasis. Cell Metab 12: 545–552, 2010.
25. Kong X, Yan D, Wu X, Guan Y, Ma X. Glucotoxicity inhibits cAMPprotein kinase A-potentiated glucose-stimulated insulin secretion in pancreatic beta-cells. J Diabetes 7: 378–385, 2015.
26. Lee YC, Asa SL, Drucker DJ. Glucagon gene 5=-flanking sequences direct expression of simian virus 40 large T antigen to the intestine, producing carcinoma of the large bowel in transgenic mice. J Biol Chem 267: 10705–10708, 1992.
27. Liu YX, Si MM, Lu W, Zhang LX, Zhou CX, Deng SL, Wu HS. Effects and molecular mechanisms of the antidiabetic fraction of Acorus calamus L. on GLP-1 expression and secretion in vivo and in vitro. J Ethnopharmacol 166: 168–175, 2015.
28. McQuaid TS, Saleh MC, Joseph JW, Gyulkhandanyan A, Manning- Fox JE, MacLellan JD, Wheeler MB, Chan CB. cAMP-mediated signaling normalizes glucose-stimulated insulin secretion in uncoupling protein-2 overexpressing beta-cells. J Endocrinol 190: 669–680, 2006.
29. Medvedev AV, Robidoux J, Bai X, Cao W, Floering LM, Daniel KW, Collins S. Regulation of the uncoupling protein-2 gene in INS-1 beta-cells by oleic acid. J Biol Chem 277: 42639–42644, 2002.
30. Meier JJ, Gallwitz B, Askenas M, Vollmer K, Deacon CF, Holst JJ, Schmidt WE, Nauck MA. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes. Diabetologia 48: 1872–1881, 2005.
31. Meier JJ, Nauck MA. Glucagon-like peptide 1(GLP-1) in biology and pathology. Diabetes Metab Res Rev 21: 91–117, 2005.
32. Muscelli E, Mari A, Casolaro A, Camastra S, Seghieri G, Gastaldelli A, Holst JJ, Ferrannini E. Separate impact of obesity and glucose tolerance on the incretin effect in normal subjects and type 2 diabetic patients. Diabetes 57: 1340–1348, 2008.
33. Nauck M, Stockmann F, Ebert R, Creutzfeldt W. Reduced incretin effect in type 2 (non-insulin-dependent) diabetes. Diabetologia 29: 46–52, 1986.
34. Nauck MA, El-Ouaghlidi A, Gabrys B, Hucking K, Holst JJ, Deacon CF, Gallwitz B, Schmidt WE, Meier JJ. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes. Regul Pept 122: 209–217, 2004.
35. Noda M, Yamashita S, Takahashi N, Eto K, Shen LM, Izumi K, Daniel S, Tsubamoto Y, Nemoto T, Iino M, Kasai H, Sharp GW, Kadowaki T. Switch to anaerobic glucose metabolism with NADH accumulation in the beta-cell model of mitochondrial diabetes. Characteristics of betaHC9 cells deficient in mitochondrial DNA transcription. J Biol Chem 277: 41817–41826, 2002.
36. Orci L, Cook WS, Ravazzola M, Wang MY, Park BH, Montesano R, Unger RH. Rapid transformation of white adipocytes into fat-oxidizing machines. Proc Natl Acad Sci USA 101: 2058–2063, 2004.
37. Park KS, Wiederkehr A, Kirkpatrick C, Mattenberger Y, Martinou JC, Marchetti P, Demaurex N, Wollheim CB. Selective actions of mitochondrial fission/fusion genes on metabolism-secretion coupling in insulin-releasing cells. J Biol Chem 283: 33347–33356, 2008.
38. Parker HE, Adriaenssens A, Rogers G, Richards P, Koepsell H, Reimann F, Gribble FM. Predominant role of active versus facilitative glucose transport for glucagon-like peptide-1 secretion. Diabetologia 55: 2445–2455, 2012.
39. Parker HE, Reimann F, Gribble FM. Molecular mechanisms underlying nutrient-stimulated incretin secretion. Expert Rev Mol Med 12: e1, 2010.
40. Parton LE, Ye CP, Coppari R, Enriori PJ, Choi B, Zhang CY, Xu C, Vianna CR, Balthasar N, Lee CE, Elmquist JK, Cowley MA, Lowell BB. Glucose sensing by POMC neurons regulates glucose homeostasis and is impaired in obesity. Nature 449: 228–232, 2007.
41. Patane G, Anello M, Piro S, Vigneri R, Purrello F, Rabuazzo AM. Role of ATP production and uncoupling protein-2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids and effects of peroxisome proliferator-activated receptor-gamma inhibition. Diabetes 51: 2749–2756, 2002.
42. Patane G, Piro S, Anello M, Rabuazzo AM, Vigneri R, Purrello F. Exposure to glibenclamide increases rat beta cells sensitivity to glucose. Br J Pharmacol 129: 887–892, 2000.
43. Piro S, Anello M, Di Pietro C, Lizzio MN, Patane G, Rabuazzo AM, Vigneri R, Purrello M, Purrello F. Chronic exposure to free fatty acids or high glucose induces apoptosis in rat pancreatic islets: possible role of oxidative stress. Metabolism 51: 1340–1347, 2002.
44. Piro S, Mascali LG, Urbano F, Filippello A, Malaguarnera R, Calanna S, Rabuazzo AM, Purrello F. Chronic exposure to GLP-1 increases GLP-1 synthesis and release in a pancreatic alpha cell line (alpha-TC1): evidence of a direct effect of GLP-1 on pancreatic alpha cells. PloS One 9: e90093, 2014.
45. Puddu A, Sanguineti R, Montecucco F, Viviani GL. Glucagon-like peptide-1 secreting cell function as well as production of inflammatory reactive oxygen species is differently regulated by glycated serum and high levels of glucose. Mediators Inflamm 2014: 923120, 2014.
46. Reimann F, Habib AM, Tolhurst G, Parker HE, Rogers GJ, Gribble FM. Glucose sensing in L cells: a primary cell study. Cell Metab 8: 532–539, 2008.
47. Saleh MC, Wheeler MB, Chan CB. Endogenous islet uncoupling protein- 2 expression and loss of glucose homeostasis in ob/ob mice. J Endocrinol 190: 659–667, 2006.
48. Takata K. Glucose transporters in the transepithelial transport of glucose. J Electron Microsc (Tokyo) 45: 275–284, 1996.
49. Theodorakis MJ, Carlson O, Michopoulos S, Doyle ME, Juhaszova M, Petraki K, Egan JM. Human duodenal enteroendocrine cells: source of both incretin peptides, GLP-1 and GIP. Am J Physiol Endocrinol Metab 290: E550–E559, 2006.
50. Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ. Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86: 3717–3723, 2001.
51. Tolhurst G, Reimann F, Gribble FM. Nutritional regulation of glucagon- like peptide-1 secretion. J Physiol 587: 27–32, 2009.
52. Vasu S, Moffett RC, McClenaghan NH, Flatt PR. Differential molecular and cellular responses of GLP-1 secreting L-cells and pancreatic alpha cells to glucotoxicity and lipotoxicity. Exp Cell Res 336: 100–108, 2015.
53. Vozza A, Parisi G, De Leonardis F, Lasorsa FM, Castegna A, Amorese D, Marmo R, Calcagnile VM, Palmieri L, Ricquier D, Paradies E, Scarcia P, Palmieri F, Bouillaud F, Fiermonte G. UCP2 transports C4 metabolites out of mitochondria, regulating glucose and glutamine oxidation. Proc Natl Acad Sci USA 111: 960–965, 2014.
54. Ward WK, Bolgiano DC, McKnight B, Halter JB, Porte D Jr. Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus. J Clin Invest 74: 1318–1328, 1984.
55. Yoshioka K, Takahashi H, Homma T, Saito M, Oh KB, Nemoto Y, Matsuoka H. A novel fluorescent derivative of glucose applicable to the assessment of glucose uptake activity of Escherichia coli. Biochim Biophys Acta 1289: 5–9, 1996.
56. Zhang CY, Baffy G, Perret P, Krauss S, Peroni O, Grujic D, Hagen T, Vidal-Puig AJ, Boss O, Kim YB, Zheng XX, Wheeler MB, Shulman GI, Chan CB, Lowell BB. Uncoupling protein-2 negatively regulates insulin secretion and is a major link between obesity, beta cell dysfunction, and type 2 diabetes. Cell 105: 745–755, 2001.
57. Zhang CY, Parton LE, Ye CP, Krauss S, Shen R, Lin CT, Porco JA Jr, Lowell BB. Genipin inhibits UCP2-mediated proton leak and acutely reverses obesity- and high glucose-induced beta cell dysfunction in isolated pancreatic islets. Cell Metab 3: 417–427, 2006.
58. Zhang H, Li J, Li Z, Luo Y. Increased GLP-1 response after gavageadministration of glucose in UCP2-deficient mice. Horm Metab Res 44: 86–90, 2012.
59. Zhang H, Li J, Liang X, Luo Y, Zen K, Zhang CY. Uncoupling protein 2 negatively regulates glucose-induced glucagon-like peptide 1 secretion. J Mol Endocrinol 48: 151–158, 2012.